Cano Health Price to Book Ratio 2020-2024 | CANOQ
Historical price to book ratio values for Cano Health (CANOQ) over the last 10 years. The current price to book ratio for Cano Health as of May 08, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Cano Health Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-06-28 | 0.24 | 0.00 | |
2024-03-31 | 0.22 | $-187.48 | 0.00 |
2023-12-31 | 5.87 | $-99.37 | -0.06 |
2023-09-30 | 25.40 | $-48.18 | -0.53 |
2023-06-30 | 139.00 | $44.09 | 3.15 |
2023-03-31 | 91.00 | $95.99 | 0.95 |
2022-12-31 | 137.00 | $100.28 | 1.37 |
2022-09-30 | 867.00 | $159.24 | 5.44 |
2022-06-30 | 438.00 | $174.28 | 2.51 |
2022-03-31 | 635.00 | $173.90 | 3.65 |
2021-12-31 | 891.00 | $167.24 | 5.33 |
2021-09-30 | 1268.00 | $179.78 | 7.05 |
2021-06-30 | 1210.00 | $186.18 | 6.50 |
2021-03-31 | 1325.00 | $16.08 | 82.41 |
2020-12-31 | 1341.00 | 0.00 | |
2020-09-30 | 1041.00 | $25.06 | 41.55 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.000B | $3.138B |
Cano Health Inc. is a value-based primary care provider for seniors and underserved communities. It provides health management programs including telehealth, prescription home delivery, wellness programs, transition of care and high-risk and complex care management. Cano Health Inc., formerly known as Jaws Acquisition Corp., is based in MIAMI. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $139.427B | 26.15 |
Elevance Health (ELV) | United States | $93.171B | 12.02 |
CVS Health (CVS) | United States | $85.832B | 10.67 |
Cencora (COR) | United States | $55.028B | 19.14 |
Natera (NTRA) | United States | $21.977B | 0.00 |
DiDi Global (DIDIY) | China | $20.426B | 31.00 |
BioMerieux (BMXMF) | France | $15.263B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.484B | 0.00 |
Solventum (SOLV) | United States | $11.527B | 12.20 |
CochLear (CHEOY) | Australia | $11.409B | 0.00 |
ICON (ICLR) | Ireland | $11.183B | 10.40 |
Doximity (DOCS) | United States | $11.080B | 57.62 |
Revvity (RVTY) | United States | $10.950B | 18.84 |
Viatris (VTRS) | United States | $10.779B | 3.67 |
Medpace Holdings (MEDP) | United States | $8.646B | 22.96 |
Avantor (AVTR) | United States | $8.368B | 12.16 |
Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
HealthEquity (HQY) | United States | $7.900B | 38.86 |
Charles River Laboratories (CRL) | United States | $6.943B | 13.60 |
Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
Bausch + Lomb (BLCO) | Canada | $4.064B | 23.96 |
BrightSpring Health Services (BTSG) | United States | $3.924B | 36.32 |
Sotera Health (SHC) | United States | $3.755B | 21.34 |
Alignment Healthcare (ALHC) | United States | $3.051B | 0.00 |
Surgery Partners (SGRY) | United States | $2.907B | 33.35 |
Concentras Parent (CON) | United States | $2.706B | 15.64 |
Organon (OGN) | United States | $2.345B | 2.49 |
Premier (PINC) | United States | $2.127B | 14.56 |
Ardent Health Partners (ARDT) | United States | $2.078B | 8.88 |
Progyny (PGNY) | United States | $2.002B | 44.09 |
GoodRx Holdings (GDRX) | United States | $1.627B | 30.29 |
PACS (PACS) | United States | $1.615B | 0.00 |
GeneDx Holdings (WGS) | United States | $1.582B | 61.93 |
Agilon Health (AGL) | United States | $1.333B | 0.00 |
Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
Pediatrix Medical (MD) | United States | $1.240B | 9.44 |
Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.004B | 0.00 | |
CareDx (CDNA) | United States | $0.857B | 13.38 |
AMN Healthcare Services Inc (AMN) | United States | $0.776B | 7.29 |
Embecta (EMBC) | United States | $0.773B | 5.30 |
QDM (QDMI) | Hong Kong, SAR China | $0.674B | 0.00 |
Nutex Health (NUTX) | United States | $0.667B | 13.08 |
Auna S.A (AUNA) | Luxembourg | $0.514B | 13.61 |
Enhabit (EHAB) | United States | $0.491B | 40.38 |
InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
LifeMD (LFMD) | United States | $0.371B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.349B | 0.00 |
SBC Medicals (SBC) | United States | $0.336B | 0.00 |
DocGo (DCGO) | United States | $0.238B | 38.83 |
Oncology Institute (TOI) | United States | $0.221B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.176B | 0.00 |
Beauty Health (SKIN) | United States | $0.155B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
So-Young (SY) | China | $0.085B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.082B | 0.00 |
OncoCyte (OCX) | United States | $0.081B | 0.00 |
Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
NeueHealth (NEUE) | United States | $0.059B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
Biodesix (BDSX) | United States | $0.051B | 0.00 |
Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
KindlyMD (KDLY) | United States | $0.023B | 0.00 |
ModivCare (MODV) | United States | $0.019B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |